Atomistry » Molybdenum » PDB 6op4-8ccq » 7orc
Atomistry »
  Molybdenum »
    PDB 6op4-8ccq »
      7orc »

Molybdenum in PDB 7orc: Human Aldehyde Oxidase in Complex with Raloxifene

Enzymatic activity of Human Aldehyde Oxidase in Complex with Raloxifene

All present enzymatic activity of Human Aldehyde Oxidase in Complex with Raloxifene:
1.2.3.1;

Protein crystallography data

The structure of Human Aldehyde Oxidase in Complex with Raloxifene, PDB code: 7orc was solved by C.Mota, C.Coelho, T.Santos Silva, M.J.Romao, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 48.85 / 2.70
Space group P 43 21 2
Cell size a, b, c (Å), α, β, γ (°) 149.033, 149.033, 268.734, 90, 90, 90
R / Rfree (%) 21.9 / 25.2

Other elements in 7orc:

The structure of Human Aldehyde Oxidase in Complex with Raloxifene also contains other interesting chemical elements:

Iron (Fe) 8 atoms

Molybdenum Binding Sites:

The binding sites of Molybdenum atom in the Human Aldehyde Oxidase in Complex with Raloxifene (pdb code 7orc). This binding sites where shown within 5.0 Angstroms radius around Molybdenum atom.
In total 2 binding sites of Molybdenum where determined in the Human Aldehyde Oxidase in Complex with Raloxifene, PDB code: 7orc:
Jump to Molybdenum binding site number: 1; 2;

Molybdenum binding site 1 out of 2 in 7orc

Go back to Molybdenum Binding Sites List in 7orc
Molybdenum binding site 1 out of 2 in the Human Aldehyde Oxidase in Complex with Raloxifene


Mono view


Stereo pair view

A full contact list of Molybdenum with other atoms in the Mo binding site number 1 of Human Aldehyde Oxidase in Complex with Raloxifene within 5.0Å range:
probe atom residue distance (Å) B Occ
A:Mo1404

b:70.7
occ:0.69
MO A:MOS1404 0.0 70.7 0.7
O2 A:MOS1404 1.9 68.4 0.7
O1 A:MOS1404 1.9 66.8 0.7
S A:MOS1404 2.3 63.2 0.7
S1' A:MTE1403 2.4 56.4 0.8
S2' A:MTE1403 2.4 63.6 0.8
C2' A:MTE1403 3.4 55.6 0.8
C1' A:MTE1403 3.4 53.3 0.8
OE2 A:GLU1270 3.9 61.4 1.0
N A:GLY1088 3.9 64.3 1.0
O A:HOH1502 3.9 57.8 1.0
CA A:GLY1087 4.0 54.6 1.0
CD A:GLU1270 4.2 64.5 1.0
C A:GLY1087 4.5 59.8 1.0
NE2 A:GLN776 4.6 42.6 1.0
CG A:GLU1270 4.6 65.0 1.0
OE1 A:GLU1270 4.7 67.6 1.0
N A:GLY808 4.7 43.4 1.0
CA A:GLY808 4.7 44.8 1.0
C3' A:MTE1403 4.8 53.6 0.8
C6 A:MTE1403 4.9 50.7 0.8
CA A:ARG921 4.9 53.0 1.0
CA A:GLY1088 4.9 62.3 1.0
N A:ARG921 5.0 48.9 1.0
C A:PHE807 5.0 44.3 1.0

Molybdenum binding site 2 out of 2 in 7orc

Go back to Molybdenum Binding Sites List in 7orc
Molybdenum binding site 2 out of 2 in the Human Aldehyde Oxidase in Complex with Raloxifene


Mono view


Stereo pair view

A full contact list of Molybdenum with other atoms in the Mo binding site number 2 of Human Aldehyde Oxidase in Complex with Raloxifene within 5.0Å range:
probe atom residue distance (Å) B Occ
B:Mo1404

b:72.4
occ:0.67
MO B:MOS1404 0.0 72.4 0.7
O2 B:MOS1404 1.9 72.5 0.7
O1 B:MOS1404 1.9 74.1 0.7
S B:MOS1404 2.3 68.6 0.7
S1' B:MTE1403 2.4 54.9 0.8
S2' B:MTE1403 2.4 60.1 0.8
O B:HOH1501 3.3 49.5 1.0
C1' B:MTE1403 3.4 49.4 0.8
C2' B:MTE1403 3.4 51.1 0.8
OE2 B:GLU1270 3.7 60.2 1.0
N B:GLY1088 4.0 62.6 1.0
CA B:GLY1087 4.1 50.6 1.0
CD B:GLU1270 4.2 61.5 1.0
CG B:GLU1270 4.6 57.4 1.0
NE2 B:GLN776 4.6 42.2 1.0
C B:GLY1087 4.6 59.2 1.0
N B:GLY808 4.7 45.1 1.0
CA B:GLY808 4.7 43.7 1.0
OE1 B:GLU1270 4.8 59.6 1.0
C3' B:MTE1403 4.8 49.0 0.8
CA B:ARG921 4.8 53.6 1.0
O B:PHE920 4.8 53.7 1.0
C6 B:MTE1403 4.8 45.9 0.8
N B:ARG921 4.9 50.0 1.0
C B:PHE920 4.9 51.9 1.0
C B:PHE807 4.9 46.5 1.0

Reference:

C.Mota, A.Diniz, C.Coelho, T.Santos-Silva, M.Esmaeeli, S.Leimkuhler, E.J.Cabrita, F.Marcelo, M.J.Romao. Interrogating the Inhibition Mechanisms of Human Aldehyde Oxidase By X-Ray Crystallography and uc(Nmr) Spectroscopy: the Raloxifene Case. J.Med.Chem. 2021.
ISSN: ISSN 0022-2623
PubMed: 34415167
DOI: 10.1021/ACS.JMEDCHEM.1C01125
Page generated: Sun Oct 6 16:58:40 2024

Last articles

W in 8QLN
W in 8RJA
V in 8WTN
Te in 8QLN
Re in 9GHX
Rb in 8Z5C
Ni in 9C0T
Ni in 9C0S
Ni in 9GP1
Ni in 9FYO
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy